Wednesday, November 8
Paige Samson, Director, Innovative Programs and Publications, FDLI
Alan G. Minsk, Partner, Arnall Golden Gregory LLP
Authors: Sonia Nath, Partner; Natasha V. Leskovsek, Of Counsel; & Madelon A. Bird, Law Clerk, Cooley LLP
Discussant: Daniel E. Orr, Senior Legal Editor (FDA Regulatory), Thomson Reuters
Moderator: Sara W. Koblitz, Director, Hyman, Phelps & McNamara PC
Authors: Liam Bendicksen, Research Assistant & C. Joseph Ross Daval, Postdoctoral Fellow, Program On Regulation, Therapeutics, And Law (PORTAL), Division of Pharmacoepidemiology & Pharmacoeconomics, Brigham & Women’s Hospital, Harvard Medical School
Discussant: Tammi Etheridge, Associate Professor of Law, Elon University School of Law
Moderator: Bridget C.E. Dooling, Assistant Professor of Law, The Ohio State University, Moritz College of Law
Author: Jeffrey Weiss, Partner, Flagstaff Ventures
Discussant: Kathleen Hoke, Professor & Director, Network for Public Health Law and Legal Resource Center for Public Health Policy, University of Maryland Francis King Carey School of Law
Moderator: Alan G. Minsk, Partner, Arnall Golden Gregory, LLP
Author: Mary Ann Chirba, John C. Ford, S.J., Distinguished Scholar and Professor of the Practice, Boston College Law School
Discussant: Wilson W. Bryan, Executive Vice President, Drug and Biological Products, Greenleaf Health, Inc.
Moderator: Erika Lietzan, William H. Pittman Professor of Law & Timothy J. Heinsz Professor of Law, University of Missouri-Columbia School of Law
Authors: Vanessa K. Burrows, Counsel, Simpson Thacher & Bartlett & Karl T. Muth, Adjunct Professor of Law and Policy, Northwestern University
Discussant: Jordan K. Paradise, Georgia Reithal Professor of Law, Co-Director, Beazley Institute for Health Law & Policy, Loyola University Chicago School of Law
Moderator: Allison M. Whelan, Assistant Professor of Law, Center for Law, Health & Society, Georgia State University College of Law
